Inspiring the Next Generation Through Research Experience for Teachers

Friday, July 21, 2017

Continue Reading

Amgen and Array Biopharma Announce Preclinical License and Collaboration Agreement In Inflammation

Thursday, July 20, 2017


Why Choose Colorado?

Tuesday, July 18, 2017


InDevR Cypher One™ Collaborative Study With FDA Published

Tuesday, July 18, 2017

BOULDER, Colo.--(BUSINESS WIRE)--InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced study results and a joint publication with the U.S. Food and Drug Administration (FDA) of “Automated interpretation of influenza hemagglutination inhibition (HAI) assays: is plate tilting necessary?” in the scientific journal PLOS ONE

AntriaBio closes $13M private placement

Monday, July 17, 2017

LOUISVILLE — AntriaBio Inc. (OTC: ANTB) closed a $13 million private placement transaction and plans to dose its first patient this month.

The biopharmaceutical company specializes in drug therapies for patients with diabetes and metabolic diseases.

Full Story via BizWest

Continue Reading

Tapped by WHO - PharmaJet Raises $3M

Tuesday, July 11, 2017

With polio vaccine in short supply, the World Health Organization has tapped a Golden-based medical device startup to help fill the gap. 

Colorado Funds Bioscience Breakthroughs

Tuesday, July 11, 2017

Colorado promotes growth and sustainability for the state’s nine identified Advanced Industries, which make up 30% of the Centennial state’s economy, through a state-led Advanced Industry (AI) Accelerator Grant Program. We’re proud to highlight this critical state funding as part of our Breakthrough Profiles series. 

Lung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy

Monday, July 10, 2017

Biodesix’ blood-based VeriStrat test helps identify squamous NSCLC patients for afatinib therapy 

Denver Named a Top 10 City for Digital Health Funding

Thursday, July 06, 2017

Denver made the cut as a top 10 city in the US for digital health funding, with five deals topping $192M total in the first half of 2017. With the mid-year funding now coming in over $6B, 2017 has broken numerous records and we anticipate this to be the biggest year yet as huge deals continue to close. 

HemoGenix Licenses Assays and Reagents to Preferred Cell Systems

Thursday, July 06, 2017

Colorado Springs, CO – HemoGenix, Inc. is pleased to announce that it has licensed the manufacturing, sales and marketing of its proprietary reagents and in vitro assay kits to Preferred Cell Systems.